Glatiramer acetate and IFN-β act on dendritic cells in multiple sclerosis

This publication has 40 references indexed in Scilit:

• Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression
  Multiple Sclerosis Journal, 2001
• Interferon β in multiple sclerosis: is IL-12 suppression the key?
  Immunology Today, 2000
• The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand
  The Journal of Experimental Medicine, 1997
• Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor
  European Journal of Immunology, 1997
• Autoimmune Pathogenesis of Multiple Sclerosis: Role of Autoreactive T Lymphocytes and New Immunotherapeutic Strategies
  Critical Reviews in Immunology, 1997
• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
  Neurology, 1995
• B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
  Cell, 1995
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
  Journal of Clinical Investigation, 1990
• T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis
  Nature, 1990